Insecticides India Ltd is Rated Sell by MarketsMOJO

Apr 14 2026 10:10 AM IST
share
Share Via
Insecticides India Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 2 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Insecticides India Ltd is Rated Sell by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO currently assigns a 'Sell' rating to Insecticides India Ltd, indicating a cautious stance towards the stock. This rating suggests that investors should consider reducing exposure or avoiding new purchases at present, based on a comprehensive evaluation of the company's quality, valuation, financial trends, and technical indicators. The rating was revised on 2 April 2026, moving from a 'Strong Sell' to a 'Sell', reflecting a modest improvement in the company’s outlook, yet still signalling concerns that warrant investor prudence.

Quality Assessment

As of 14 April 2026, Insecticides India Ltd holds an average quality grade. This assessment considers the company’s operational consistency, profitability, and growth prospects. Over the past five years, the company has demonstrated modest growth, with net sales increasing at an annualised rate of 8.11% and operating profit growing at 15.68%. While these figures indicate some expansion, the pace is relatively subdued for a smallcap in the pesticides and agrochemicals sector, which often demands stronger growth to justify higher ratings.

Valuation Perspective

The valuation grade for Insecticides India Ltd is currently attractive. This suggests that the stock is trading at a price level that may offer value relative to its earnings and asset base. Investors looking for potential bargains might find this appealing, especially given the stock’s recent price movements. The stock has delivered a 7.58% return over the past year and a 16.84% gain in the last month, signalling some positive momentum despite broader challenges. However, valuation alone does not offset other concerns that impact the overall rating.

Financial Trend Analysis

The financial grade remains negative, reflecting recent operational difficulties. The latest quarterly results ending December 2025 reveal a 39.6% decline in profit after tax (PAT), which stood at ₹10.49 crores. Additionally, the company’s PBDIT for the quarter was at a low of ₹27.39 crores, signalling margin pressures. The debtor turnover ratio for the half-year is also at a concerning low of 3.18 times, indicating potential inefficiencies in receivables management. These factors collectively weigh heavily on the company’s financial health and contribute to the cautious rating.

Technical Outlook

From a technical standpoint, the stock is mildly bearish. Despite a strong one-day gain of 4.14% and a one-week rise of 8.87%, the six-month performance shows a decline of 8.24%, and the year-to-date return is negative at -6.06%. This mixed technical picture suggests short-term rallies amid longer-term weakness, which may not yet be sufficient to alter the overall negative trend. Investors should monitor price action closely for confirmation of any sustained recovery.

Sector and Market Context

Insecticides India Ltd operates within the pesticides and agrochemicals sector, a space that is sensitive to agricultural cycles, regulatory changes, and commodity price fluctuations. The company’s smallcap status means it is more vulnerable to market volatility and liquidity constraints compared to larger peers. While the sector has pockets of growth driven by increasing demand for crop protection, Insecticides India’s current fundamentals and financial trends suggest it is not positioned to capitalise strongly on these opportunities at this time.

Investor Implications

For investors, the 'Sell' rating implies a recommendation to exercise caution. The attractive valuation may tempt some to consider the stock for a turnaround play, but the negative financial trends and average quality grade highlight risks that could limit near-term gains. The mildly bearish technical stance further advises prudence. Investors should weigh these factors carefully against their risk tolerance and portfolio strategy before making decisions involving Insecticides India Ltd.

Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.

  • - Recent Top 1% qualifier
  • - Impressive market performance
  • - Sector leader

See What's Driving the Rally →

Summary of Recent Performance Metrics

As of 14 April 2026, the stock’s recent returns show a mixed performance. The one-day gain of 4.14% and one-month increase of 16.84% indicate short-term buying interest. However, the six-month return is negative at -8.24%, and the year-to-date return is down by 6.06%. Over the past year, the stock has managed a modest 7.58% gain, which is below what might be expected for a smallcap with growth aspirations. These figures reflect the ongoing challenges faced by the company amid a competitive and cyclical sector environment.

Outlook and Considerations

While the 'Sell' rating reflects current concerns, investors should continue to monitor key indicators such as quarterly earnings, debtor turnover improvements, and any shifts in technical momentum. The company’s ability to stabilise profits and improve operational efficiency will be critical to altering its outlook. Until then, the cautious stance remains justified given the present data.

Conclusion

Insecticides India Ltd’s 'Sell' rating by MarketsMOJO, last updated on 2 April 2026, is grounded in a balanced analysis of quality, valuation, financial trends, and technical factors as of 14 April 2026. While valuation appears attractive, the negative financial trend and average quality grade temper enthusiasm. The mildly bearish technical outlook further supports a prudent approach. Investors should carefully consider these factors in the context of their investment goals and risk appetite.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News